Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Urinary bladder Stories

2011-03-22 09:36:00

TOKYO, March 22, 2011 /PRNewswire-FirstCall/ -- Astellas Pharma Inc.(TSE:4503,"Astellas") ( http://www.astellas.com/en/corporate/) today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition[1,2]. These data were presented for the first time this week at...

2011-03-18 09:39:00

EAST NORRITON, Pa., March 18, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Friday, March 25, 2011 at 8:30 a.m. EDT to provide a business update and discuss its fourth quarter 2010 financial results. To participate in the call, please dial 1-888-680-0879 (domestic) or 1-617-213-4856 (international) and reference access code 55045101. This conference call will also be webcast...

2011-03-03 12:13:00

Fifth Most Frequently Diagnosed Cancer in U.S. Affects Approximately 70,000 Americans Each Year LOS ANGELES, March 3, 2011 /PRNewswire-USNewswire/ -- Bladder cancer is the fifth most commonly diagnosed cancer, and there are more than 600,000 survivors in the United States, yet most people know nothing about it. To help enhance the public's understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network...

2011-03-02 00:00:26

Michelle Persun, MD, has joined Urologic Consultants of Southeastern Pennsylvania. She has a special interest in treating incontinence in women and men and in treating female urologic problems. She is spearheading a new specialty center for incontinence and pelvic disorders at One Presidential Boulevard in Bala Cynwyd, Pa. The center offers a multidisciplinary, holistic approach to treating stress incontinence, overactive bladder, pelvic organ prolapse, pelvic pain, urinary tract infections...

2011-02-25 08:42:21

By Rhonda Craig, Ivanhoe Health Correspondent (Ivanhoe Newswire) -- A blood test may be able to accurately detect markers of bladder cancer. A new study shows that cancer associated with a specific methylation pattern (a chemical alteration to DNA that affects which genes are expressed in cells) can readily be detected in the blood. Since it's not possible to document and assess all of the carcinogenic exposures a person has had in life, researchers hoped to find a more precise way to predict...

2011-02-16 07:00:00

EAST NORRITON, Pa., Feb. 16, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that it has been engaged in negotiations with a publicly traded company relating to the acquisition of Tengion through a stock-for-stock merger. As a result of the recent increases in the trading price and volume of Tengion's common stock, Tengion's potential acquirer has terminated merger negotiations. As has previously been stated in the Company's filings...

2011-02-07 07:30:00

EAST NORRITON, Pa., Feb. 7, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present at the upcoming 13th Annual BIO CEO & Investor Conference on Monday, February 14, 2011, at 2:00 p.m. EST. Dr. Nichtberger will also participate in a panel discussion titled "IPO Window-Creaking Open or Wide Open?" the following day on Tuesday, February 15, 2011, at...

2011-01-20 06:00:00

MINNEAPOLIS, Jan. 20, 2011 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI) announced today that it will release financial results for the third quarter ended December 31, 2010, at the market close on Thursday, January 27, 2011. The Company will host a conference call to discuss these results on Thursday, January 27, 2011 at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and...

2010-11-23 12:41:37

Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient's own bone marrow. The research, published in Stem Cells, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies. The research, led by Drs Arun Sharma and Earl Cheng from the Feinberg School of Medicine at Northwestern University, focused on bone marrow...

2010-11-23 07:30:00

EAST NORRITON, Pa., Nov. 23, 2010 /PRNewswire/ -- Tengion, Inc (Nasdaq: TNGN), a leader in regenerative medicine, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present at the upcoming Piper Jaffray 22nd Annual Health Care Conference on Wednesday, December 1, 2010, at 9:30 a.m. EST. A live audio webcast of the presentation can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TNGN&item_id=3494808 or under...


Latest Urinary bladder Reference Libraries

Urinary Bladder
2013-01-18 10:29:10

The urinary bladder is a hollow organ that holds the urine, a fluid by-product excreted from the kidneys. Once enough urine is collected within the bladder, pressure initiates the process of urination which expels the urine from the system completely. Formation and Orientation Bladders are a common organ in the Animal Kingdom but are unique in characteristics to each species. Within the human species, there are some differences between female and male bladders. The first difference is...

More Articles (1 articles) »